We focus on
critical care

SERB has consolidated a global leading position in Critical Care with Emergency Care (wide range of lifesaving medical countermeasures and intensive care medicines) and Surgery portfolio (drugs and medical devices for supportive care as well as diagnostic agents).

More Info

We focus on
rare diseases

SERB has extended its Rare Diseases portfolio in both Neurology (with treatments for severe epileptic and neuromuscular conditions) and Metabolic Disorders.

More Info

We focus on
global presence

SERB is a global pharmaceutical group with a direct presence in Europe, the Middle East and Australia, plus over 80 countries including USA and Japan through a broad network of experienced distributors.


Welcome to SERB

SERB is a global specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.

Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.

Our commitment is to continue to offer essential drugs meeting Public Health needs.